Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes (VICTORY)

JW Pharmaceutical

Status: Completed

Conditions: Hypercholesterolemia

Study type: Observational

Funder types: Industry

Identifiers

NCT07382778

JW21403

Details and patient eligibility

About

A Multi-center, Open-label, Observational Study to Compare and Evaluate the Efficacy and Safety of Livalozet® according to the Presence or Absence of Diabetes Mellitus in Hypercholesterolemia Patients

Full description

A Multi-center, Open-label, Observational Study

Enrollment: 1,538 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men and women aged ≥19 years
• Diagnosed with hypercholesterolemia
• LDL-C level meets cardiovascular/cerebrovascular risk group classification
• Willing to participate for 12 months
• Provided written informed consent

Exclusion criteria

- Contraindications to Livalozet®

Trial design

1,538 participants in 2 patient groups

Hypercholesterolemia with Diabetes Mellitus

Description:

Observational study; LDL-C and lipid parameters will be followed; no intervention assigned.

Hypercholesterolemia without Diabetes Mellitus

Description:

Observational study; LDL-C and lipid parameters will be followed; no intervention assigned.